ACER THERAPEUTICS INC (ACER) Stock Analyst Earnings Estimates
NASDAQ:ACER - Nasdaq - US00444P1084 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.26M | -100.00% | 8.844M | 49.402M 458.59% | 112.14M 126.99% | 150.89M 34.56% | 173.65M 15.08% | 188.61M 8.62% | 200.55M 6.33% | 210.34M 4.88% | |||
| EBITDA YoY % growth | -29.84M -37.64% | -22.73M 23.83% | -15.877M 30.15% | N/A -54.61% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -29.9M -37.72% | -22.8M 23.75% | -15.948M 30.05% | -25.968M -54.34% | -15.091M 38.69% | 16.361M 208.41% | 70.62M 331.64% | 104.75M 48.33% | 124.16M 18.53% | 136.5M 9.94% | 146.06M 7.00% | 153.64M 5.19% | |
| Operating Margin | N/A | N/A | -1,265.75% | N/A | -170.64% | 33.12% | 62.97% | 69.42% | 71.50% | 72.37% | 72.83% | 73.04% | |
| EPS YoY % growth | -2.91 -18.78% | -2.06 29.21% | -0.88 57.28% | -1.51 -88.64% | -0.74 55.45% | 0.12 116.55% | 0.77 525.00% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.13 58.87% | -0.08 85.83% |
| Revenue Q2Q % growth | 2.601M | 6.243M |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -3.41M 34.91% | -2.204M 58.12% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.33 -94.12% | -0.26 | -0.07 | -26.87% |
| Q1 2023 Q2Q % growth | -0.77 -20.31% | -0.29 | -0.48 | -164.88% |
| Q4 2022 Q2Q % growth | -0.54 -74.19% | -0.38 | -0.16 | -43.08% |
| Q3 2022 Q2Q % growth | -0.31 -34.78% | -0.70 | 0.39 | 55.52% |
| Q2 2022 Q2Q % growth | -0.17 26.09% | -0.58 | 0.41 | 70.76% |
| Q1 2022 Q2Q % growth | -0.64 -481.82% | -0.42 | -0.22 | -51.19% |
| Q4 2021 Q2Q % growth | -0.31 38.00% | -0.01 | -0.30 | -2,939.22% |
| Q3 2021 Q2Q % growth | -0.23 54.90% | -0.29 | 0.06 | 19.47% |
| Q2 2021 Q2Q % growth | -0.23 58.93% | -0.37 | 0.14 | 37.10% |
| Q1 2021 Q2Q % growth | -0.11 77.55% | -0.45 | 0.34 | 75.36% |
| Q4 2020 Q2Q % growth | -0.50 1.96% | -0.42 | -0.08 | -20.29% |
| Q3 2020 Q2Q % growth | -0.51 1.92% | -0.47 | -0.04 | -8.70% |
| Q2 2020 Q2Q % growth | -0.56 48.62% | -0.38 | -0.18 | -45.78% |
| Q1 2020 Q2Q % growth | -0.49 37.97% | -0.41 | -0.08 | -20.10% |
| Q4 2019 Q2Q % growth | -0.51 | -0.49 | -0.02 | -3.73% |
| Q3 2019 Q2Q % growth | -0.52 | -0.59 | 0.07 | 11.21% |
| Q2 2019 Q2Q % growth | -1.09 | -0.80 | -0.29 | -36.71% |
| Q1 2019 Q2Q % growth | -0.79 | -0.83 | 0.04 | 5.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | 2.55M | -2.55M | -100.00% |
| Q4 2021 Q2Q % growth | 360K | 3.4M | -3.04M | -89.41% |
| Q2 2021 Q2Q % growth | 1.02M | -1.02M | -100.00% | |
| Q1 2021 Q2Q % growth | 4M | 680.003K | 3.32M | 488.23% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -6.62% |
| Revenue | N/A | N/A | 0% | -16.17% |